ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta Т. 17, No. 2 , 2024
P. 7-9, Bibliography 6, Engl.
UDC::577.218+616-006
DOI: https://doi.org/10.15407/biotech17.02.007
COMPREHENSIVE OVERVIEW OF ADAPTOR PROTEIN RUK/CIN85 ROLES IN CANCER
I. Horak 1, 2, T. Skaterna 1, O. Hudkova 1, N. Latysho 1, O. Khudiakova 1, K. Tokarchuk1, I. Krysiuk1, T. Kishko1, L. Knopfová 2,,.L. Drobot1
1 Palladin Institute of Biochemistry of National Academy of Sciences (NASU), Kyiv, Ukraine
2 Masaryk University, Brno, the Czech Republic
Aim. This study is focused on a comprehensive overview of mechanisms and processes involved in the acquisition of cancer cell plasticity in a manner dependent on the adapter protein Ruk/CIN85 (in rodents, Ruk — regulator of ubiquitous kinase; in human CIN85 — Cbl-interacting protein of 85 kDa, encoded by SH3KBP1 gene)..
Methods. Gene expression was evaluated using RT2-PCR and Western blotting, cell proliferation and survival were analyzed using MTT and/or dye exclusion assays, motility was assessed by scratch test and Transwell assay, enzyme activities were measured using spectrophotometric assays. In vivo metastasis were studies using experimental metastasis model.
Conclusion. This study discloses various aspects of cancer cells plasticity, such as EMT, stemness, metabolic changes, ECM components, and drug resistance in dependence on adaptor protein Ruk/CIN85 expression level.
Key words: adaptor protein Ruk/CIN85, breast cancer, lung cancer, osteosarcoma, motility,metastasis, cancer stem cells, drug resistance, cancer cell plasticity.
© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2024
References
...
1. Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31‒46. https://doi.org/10.1158/2159-8290.CD-21-1059
2. Samoylenko A, Vynnytska-Myronovska B, Byts N, Kozlova N, Basaraba O, Pasichnyk G, Palyvoda K, Bobak Y, Barska M, Mayevska O, Rzhepetsky Y, Shuvayeva H, Lyzogubov V, Usenko V, Savran V, Volodko N, Buchman V, Kietzmann T, Drobot L. Increased levels of the HER1 adaptor protein Rukl/CIN85 contribute to breast cancer malignancy. Carcinogenesis. 2012; 33(10):1976‒1984. https://doi.org/10.1093/carcin/bgs228
3. Yakymovych I, Yakymovych M, Zang G, Kozlova N., Basaraba O., Pasichnyk G., Pasichnyk K., Pasichnyk Ya., Barska M., Mayevska O., Rzhepetsky Yu., Shuvayeva H., Lyzogubov L., Usenko V., Savran V., Volodko N., Buchman V., Kietzmann T., Drobot. CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface. J Cell Biol. 2015;210(2):319‒332. https://doi.org/10.1083/jcb.201411025.
4. Hua XY, Bie XX, Cheng X, Zhang SG. High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma. Mol Med Rep. 2021;23(1):12. https://doi.org/10.3892/mmr.2020.11650.
5. Wakasaki T, Masuda M, Niiro H, Jabbarzadeh-Tabrizi S., Noda K., Taniyama T., Komune S., Akashi K. A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway. Neoplasia. 2010;12(10):789‒796. https://doi.org/10.1593/neo.10396.
6. Cascio S, Finn OJ. Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis. Cancers (Basel). 2015;7(1):342‒352. Published 2015 Feb 10. https://doi.org/10.3390/cancers7010342.